- Home
- ALRM vs RCUS Comparison
ALRM vs RCUS Comparison
Compare ALRM & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALRM | RCUS |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ALRM | RCUS |
|---|---|---|
| Price | $52.54 | $22.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $64.67 | $29.38 |
| AVG Volume (30 Days) | 481.4K | ★ 2.4M |
| Earning Date | 11-06-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.77 | N/A |
| EPS | ★ 2.36 | N/A |
| Revenue | ★ $991,770,000.00 | $240,000,000.00 |
| Revenue This Year | $8.53 | N/A |
| Revenue Next Year | $4.12 | N/A |
| P/E Ratio | $22.36 | ★ N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $46.65 | $6.50 |
| 52 Week High | $65.76 | $26.40 |
Technical Indicators
Market Signals| Indicator | ALRM | RCUS |
|---|---|---|
| Relative Strength Index (RSI) | 53.83 | 54.13 |
| Support Level | $51.38 | $21.81 |
| Resistance Level | $53.61 | $22.70 |
| Average True Range (ATR) | 0.98 | 1.28 |
| MACD | 0.01 | -0.50 |
| Stochastic Oscillator | 49.04 | 48.60 |
Price Performance
Historical ComparisonAbout ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.